VOL. XCIV, NO. 247
* WIDE MOAT STOCKS COMPARISON *
NO ADVICE
Monday, December 29, 2025
Stock Comparison
FANUC CORPORATION vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
FANUC CORPORATION
6954 · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into FANUC CORPORATION's moat claims, evidence, and risks.
View 6954 analysisGSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: FANUC CORPORATION leads (76 / 100 vs 62 / 100 for GSK plc).
- Segment focus: FANUC CORPORATION has 4 segments (41.3% in Industrial Robots (ROBOT) - robot systems and controllers); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: FANUC CORPORATION has 6 moat types across 3 domains; GSK plc has 4 across 3.
Primary market context
FANUC CORPORATION
Industrial Robots (ROBOT) - robot systems and controllers
Industrial robot systems for welding, handling, assembly, painting, machine tending, etc.
Global
Manufacturers (automotive, electronics, general industry)
Robot OEM (hardware + controllers)
41.3%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
FANUC CORPORATION strengths
GSK plc strengths
Segment mix
FANUC CORPORATION segments
Full profile >Factory Automation (FA) - CNC, servos, lasers
Oligopoly
Industrial Robots (ROBOT) - robot systems and controllers
Oligopoly
ROBOMACHINE - ROBODRILL, ROBOSHOT, ROBOCUT
Competitive
Service - parts, maintenance, and customer support
Quasi-Monopoly
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.